Literature DB >> 15072852

Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?

Anna M Blom1, Bruno O Villoutreix, Björn Dahlbäck.   

Abstract

The complement system constitutes an important component of the defence against foreign organisms, functioning both in innate and adaptive immune systems. It is potentially harmful also to the own organism and is therefore tightly regulated by a number of membrane-bound and soluble factors. C4b-binding protein (C4BP) is a potent circulating soluble inhibitor of the classical and lectin pathways of complement. In recent years, the relationships between the structure of C4BP and its functions have been elucidated using a combination of computer-based molecular analysis and recombinant DNA technologies. Moreover, two novel functions have recently been ascribed to C4BP. One is the ability of C4BP to localize complement regulatory activity to the surface of apoptotic cells via its interaction with the membrane-binding vitamin K-dependent protein S. The other is the ability of C4BP to act as a survival factor for B cells due to an interaction with CD40. The complement regulatory activity of C4BP is not only beneficial because it is also explored by pathogens such as Neisseria gonorrhoeae, Bordetella pertussis, Streptococcus pyogenes, Escherichia coli K1, and Candida albicans, that bind C4BP to their surfaces. This contributes to the serum resistance and the pathogenicity of these bacteria. In this review, the structural requirements and functional importance of the interactions between C4BP and its various ligands are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072852     DOI: 10.1016/j.molimm.2003.12.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  70 in total

1.  Lack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation.

Authors:  Riikka Tulamo; Juhana Frösen; Anders Paetau; Sanna Seitsonen; Juha Hernesniemi; Mika Niemelä; Irma Järvelä; Seppo Meri
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 2.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

3.  A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.

Authors:  Monika Jusko; Jan Potempa; Abdulkarim Y Karim; Miroslaw Ksiazek; Kristian Riesbeck; Peter Garred; Sigrun Eick; Anna M Blom
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

5.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

6.  Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.

Authors:  Anna M Blom; Michal Magda; Lisa Kohl; Jutamas Shaughnessy; John D Lambris; Sanjay Ram; David Ermert
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

Review 7.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

8.  Functional consequences of cleavage, dissociation and exocytotic release of ZP3R, a C4BP-related protein, from the mouse sperm acrosomal matrix.

Authors:  Mariano G Buffone; Kye-Seong Kim; Birgit J Doak; Esmeralda Rodriguez-Miranda; George L Gerton
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

Review 9.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

10.  Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.

Authors:  Somayeh Pouyanfard; Gloria Spagnoli; Lorenzo Bulli; Kathrin Balz; Fan Yang; Caroline Odenwald; Hanna Seitz; Filipe C Mariz; Angelo Bolchi; Simone Ottonello; Martin Müller
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.